News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
53,310 Results
Type
Article (2705)
Company Profile (20)
Press Release (50579)
Multimedia
Podcasts (2)
Webinars (5)
Section
Business (14124)
Career Advice (97)
Deals (2360)
Drug Delivery (6)
Drug Development (5697)
Employer Resources (30)
FDA (1235)
Job Trends (1387)
News (24178)
Policy (2361)
Tag
2027 BioCapital Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (250)
Accelerated approval (2)
Allergies (32)
Alliances (4469)
ALS (12)
Alzheimer's disease (82)
Antibody-drug conjugate (ADC) (22)
Approvals (1286)
Artificial intelligence (57)
Autoimmune disease (20)
Automation (2)
Bankruptcy (7)
Best Places to Work (1122)
BIOSECURE Act (2)
Biosimilars (8)
Biotechnology (10)
Bladder cancer (6)
Brain cancer (8)
Breast cancer (59)
Cancer (459)
Cardiovascular disease (32)
Career advice (89)
Career pathing (1)
CAR-T (23)
CDC (1)
Cell therapy (53)
Cervical cancer (2)
Clinical research (5081)
Collaboration (215)
Compensation (56)
Complete response letters (2)
COVID-19 (196)
CRISPR (8)
C-suite (107)
Cystic fibrosis (9)
Data (629)
Depression (2)
Dermatology (2)
Diabetes (37)
Diagnostics (464)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (31)
Drug pricing (8)
Duchenne muscular dystrophy (15)
Earnings (4639)
Editorial (2)
Employer branding (3)
Employer resources (24)
Events (7370)
Executive appointments (137)
FDA (1492)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (187)
Gene editing (14)
Generative AI (4)
Gene therapy (73)
GLP-1 (90)
Government (327)
Grass and pollen (2)
Guidances (53)
Healthcare (1573)
HIV (22)
Huntington's disease (3)
IgA nephropathy (2)
Immunology and inflammation (12)
Immuno-oncology (12)
Indications (11)
Infectious disease (220)
Inflammatory bowel disease (18)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (15)
Interviews (7)
IPO (781)
IRA (2)
Job creations (329)
Job search strategy (78)
JPM (3)
Labor market (5)
Layoffs (45)
Leadership (5)
Legal (446)
Liver cancer (9)
Longevity (1)
Lung cancer (67)
Lymphoma (40)
Machine learning (7)
Management (11)
Manufacturing (101)
MASH (43)
Medical device (926)
Medtech (930)
Mergers & acquisitions (1672)
Metabolic disorders (113)
mRNA (5)
Multiple sclerosis (12)
NASH (4)
Neurodegenerative disease (32)
Neuropsychiatric disorders (2)
Neuroscience (168)
NextGen: Class of 2026 (357)
Non-profit (532)
Now hiring (4)
Obesity (27)
Opinion (24)
Ovarian cancer (12)
Pain (16)
Pancreatic cancer (19)
Parkinson's disease (22)
Partnered (4)
Patents (22)
Patient recruitment (46)
Peanut (20)
People (4801)
Pharmaceutical (4)
Phase 1 (1300)
Phase 2 (2132)
Phase 3 (2073)
Pipeline (607)
Policy (15)
Postmarket research (211)
Preclinical (564)
Press Release (9)
Prostate cancer (30)
Psychedelics (1)
Radiopharmaceuticals (20)
Rare diseases (96)
Real estate (666)
Recruiting (9)
Regulatory (1942)
Reports (12)
Research institute (218)
Resumes & cover letters (7)
Rett syndrome (1)
RSV (8)
Schizophrenia (4)
Series A (25)
Series B (21)
Sickle cell disease (9)
Spinal muscular atrophy (9)
Sponsored (3)
Startups (304)
Stomach cancer (1)
Supply chain (11)
Tariffs (2)
The Weekly (2)
Vaccines (94)
Venture capital (4)
Weight loss (17)
Women's health (7)
Worklife (2)
Date
Last 7 days (56)
Last 30 days (209)
Last 365 days (2394)
2026 (609)
2025 (2682)
2024 (3107)
2023 (3378)
2022 (5887)
2021 (4148)
2020 (3410)
2019 (3595)
2018 (2634)
2017 (2645)
2016 (2657)
2015 (3089)
2014 (2289)
2013 (1748)
2012 (1829)
2011 (1803)
2010 (1561)
Location
Africa (84)
Alabama (2)
Arizona (16)
Asia (2722)
Australia (388)
California (759)
Canada (201)
China (74)
Colorado (15)
Connecticut (19)
Delaware (32)
Europe (18448)
Florida (66)
Georgia (22)
Idaho (2)
Illinois (70)
India (11)
Indiana (22)
Iowa (2)
Japan (38)
Kansas (9)
Kentucky (2)
Louisiana (4)
Maine (1)
Maryland (69)
Massachusetts (479)
Michigan (13)
Minnesota (23)
Missouri (8)
Montana (2)
Nebraska (1)
Nevada (4)
New Hampshire (4)
New Jersey (253)
New Mexico (6)
New York (267)
North Carolina (68)
Northern California (493)
Ohio (16)
Oklahoma (8)
Oregon (3)
Pennsylvania (217)
Rhode Island (2)
South America (106)
South Carolina (8)
Southern California (186)
Tennessee (11)
Texas (189)
United States (2674)
Utah (17)
Virginia (23)
Washington D.C. (7)
Washington State (37)
West Virginia (1)
Wisconsin (9)
53,310 Results for "foster wheeler france".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Wheeler Bio Appoints Jay Benson as Chief Operating Officer
October 2, 2025
·
3 min read
Press Releases
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
August 19, 2025
·
2 min read
Press Releases
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
January 8, 2026
·
11 min read
Press Releases
Wheeler Bio and MindImmune Therapeutics Sign CDMO Partnership Agreement to Support MindImmune’s Lead Alzheimer’s Prevention Program, MITI-101
September 18, 2025
·
3 min read
Press Releases
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
November 26, 2025
·
3 min read
Press Releases
Apellis Announces Craig Wheeler to Join the Board of Directors
April 22, 2025
·
3 min read
Business
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC® (Chemistry, Manufacturing and Controls) platform.
February 21, 2024
·
4 min read
Press Releases
Wheeler Bio Announces Oversubscribed $35M Series, Plans for Expansion and Continued Growth
March 20, 2025
·
3 min read
Press Releases
SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France
March 12, 2026
·
2 min read
Press Releases
Wheeler Bio Appoints Industry Veteran Patrick Lucy as Chief Executive Officer
October 9, 2024
·
3 min read
1 of 5,331
Next
